Warning: openssl_decrypt(): IV passed is 20 bytes long which is longer than the 16 expected by selected cipher, truncating in /home/hotwnews/public_html/wp-content/plugins/seo-by-rank-math/includes/class-data-encryption.php on line 122

Warning: openssl_decrypt(): IV passed is 21 bytes long which is longer than the 16 expected by selected cipher, truncating in /home/hotwnews/public_html/wp-content/plugins/seo-by-rank-math/includes/class-data-encryption.php on line 122

Warning: openssl_decrypt(): IV passed is 20 bytes long which is longer than the 16 expected by selected cipher, truncating in /home/hotwnews/public_html/wp-content/plugins/seo-by-rank-math/includes/class-data-encryption.php on line 122

Warning: openssl_decrypt(): IV passed is 21 bytes long which is longer than the 16 expected by selected cipher, truncating in /home/hotwnews/public_html/wp-content/plugins/seo-by-rank-math/includes/class-data-encryption.php on line 122
E.U. Regulator Says J.&J. Shot Should Carry Rare Clot Risk Label | HotWnews.com Hot World News Daily News
E.U. Regulator Says J.&J. Shot Should Carry Rare Clot Risk Label

E.U. Regulator Says J.&J. Shot Should Carry Rare Clot Risk Label

E.U. Regulator Says J.&J. Shot Should Carry Rare Clot Risk Label

E.U. Regulator Says J.&J. Shot Should Carry Rare Clot Risk Label

Even though the E.U. regulator eventually found that the benefits of the AstraZeneca vaccine outweighed risks, and that E.U. members should use it, the damage had been done. Many Europeans have been refusing to take the vaccine, and several E.U. countries have limited its use to older people, as most of those affected by the rare clots were younger than 60. The EMA declined to name at-risk groups of the population regarding both the AstraZeneca and Johnson & Johnson vaccines, even though most cases reported were among younger women. The agency said it didn’t have sufficient information to draw definitive conclusions.

The E.U. last week announced it was boosting its supply of the Pfizer-BioNTech vaccine, and was negotiating a new deal for future booster shots with the company for 2022 and 2023, signaling it was going to prioritize vaccines, like Pfizer’s and Moderna’s, that use the mRNA technology.

But the Johnson & Johnson vaccine has been an important component of vaccination plans from the United States to South Africa.

U.S. health officials called for a pause in the vaccine’s use on April 13 to examine a rare blood-clotting disorder that emerged in a small number of recipients. Johnson & Johnson suspended its E.U. rollout immediately afterward. E.U. countries had just begun receiving their first shipments of the vaccine, and all but Poland followed the company’s guidance and have not began administering it.

Six cases of the rare blood clotting that emerged in the U.S. were all women between the ages of 18 and 48, and developed the illness within one to three weeks of vaccination. One woman in Virginia died, and a second woman in Nebraska has been hospitalized in critical condition.

At a meeting of expert advisers at the Centers for Disease Control and Prevention on Wednesday, a representative from Johnson & Johnson presented information on two new cases, bringing the total to eight. The EMA said in their announcement that they reviewed all eight cases.

On Monday, the C.D.C. said that while federal health officials were investigating “a handful” of new, unconfirmed reports that had emerged since the pause nationwide, “no additional cases of the rare form of blood clots post-vaccination with the Johnson & Johnson vaccine have been confirmed.”

Dr. Anthony S. Fauci, the United States’ leading infectious disease expert, said previously that he anticipated a decision about whether to resume administering the Johnson & Johnson vaccine this Friday, when the expert panel that is advising the agency is scheduled to meet again.




Source link

Check Also

Man Hangs On for Life After Winds Shatter Glass Bridge in China

Man Hangs On for Life After Winds Shatter Glass Bridge in China

Man Hangs On for Life After Winds Shatter Glass Bridge in China Man Hangs On …